Sotera Health Co
NASDAQ:SHC
Sotera Health Co
NASDAQ:SHC
Price:
11.27 USD
0.63%
Market Closed
Updated:
May 2, 2024
Section:
Relative Value
The Relative Value of one
SHC
stock under the Base Case scenario is
33.27
USD.
Compared to the current market price of 11.27 USD,
Sotera Health Co
is
Undervalued by 66%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SHC
Relative Value
Base Case
33.27
USD
Undervaluation 66%
Valuation Multiples
Multiples Across Competitors
SHC Competitors Multiples
Sotera Health Co Competitors
Sotera Health Co Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Sotera Health Co
NASDAQ:SHC
|
3.2B USD | 3 | 62.4 | 11.9 | 18.7 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
222.3B USD | 5.2 | 37.1 | 22.9 | 33.6 | |
| US |
|
Danaher Corp
NYSE:DHR
|
182.8B USD | 4.2 | 22.7 | 16.5 | 20.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
42.3B USD | 2.8 | 31.1 | 16.9 | 26.1 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
40.6B USD | 6 | 32.9 | 26.3 | 31.6 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
55.4T KRW | 15 | 64.6 | 34 | 49 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37.3B CHF | 5.5 | 57.1 | 19.6 | 28.7 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.9B USD | 7.1 | 34.1 | 23.8 | 26.5 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.5B USD | 9.1 | 46.7 | 32.4 | 39.3 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
24.9B USD | 3 | 36.5 | 16.5 | 25.4 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
19B EUR | 7 | 74.6 | 32.1 | 52.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
